Form D — THERALASE TECHNOLOGIES INC /FI
0001062993-26-004733 · filed Aug 31, 2026
Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.
Check this disclosure on SEC EDGAR · More Other filings
Offering
- Industry
- Other
- Exemptions
- 06b
- Reported offering amount
- $168,695
- Reported amount sold
- $72,298
- Minimum investment
- $0
- Investors
- 1
- Sales commission
- $0
- Finders' fees
- $0
Issuer
- Name
- THERALASE TECHNOLOGIES INC /FI
- CIK
- 923883
- Entity
- Corporation
- Jurisdiction
- ONTARIO, CANADA
- Year incorporated
- —
- Address
- 41 Hollinger Road
Toronto, A6 M4B 3G4 - Phone
- (416) 699-5273
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Roger Dumoulin-White · Executive OfficerToronto, A6 Find on LinkedIn ↗
-
Kristina Hachey · Executive OfficerToronto, A6 Find on LinkedIn ↗
-
Arkady Mandel · Executive OfficerToronto, A6 Find on LinkedIn ↗
-
Matthew Perraton · DirectorToronto, A6 Find on LinkedIn ↗
-
Randy Bruder · DirectorToronto, A6 Find on LinkedIn ↗
-
Kaouthar Lbiati · DirectorToronto, A6 Find on LinkedIn ↗
-
Guy Anderson · DirectorToronto, A6 Find on LinkedIn ↗
Other filings from this issuer
View the original filing on SEC EDGAR ↗